Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...
On June 7th, Era Biology hosted a live webinar for Latin America. The webinar focuses on antimicrobial resistance problem. Since 2005, the antibiotic resistance rate of bacteria has been increasing...
Tianjin, China – August 9, 2022 – Tianjin Era Biology Technology Co., Ltd was award as National Professionalization, Refinement, Characteristic and Novelty “Little Giant” by National Ministry of In...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...
Day 3 at ISHAM —- FACIS Received High Recognition
New Delhi, India – September 22, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Socie...
(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...